Skip to main content
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
17.30
+0.27 (1.59%)
Apr 29, 2026, 3:00 PM CST

SHA:688488 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
7,2806,8713,3075,2644,4276,539
Upgrade
Market Cap Growth
70.61%107.76%-37.17%18.91%-32.31%-37.22%
Upgrade
Enterprise Value
7,4967,0393,4025,1474,0845,910
Upgrade
Last Close Price
17.3016.337.8612.5110.5415.57
Upgrade
PS Ratio
10.129.567.9212.8018.1325.57
Upgrade
PB Ratio
6.786.403.104.683.694.99
Upgrade
P/TBV Ratio
11.4010.765.225.284.145.60
Upgrade
P/OCF Ratio
412.87389.72----
Upgrade
EV/Sales Ratio
10.429.798.1412.5116.7223.11
Upgrade
EV/EBITDA Ratio
83.4180.80----
Upgrade
EV/EBIT Ratio
215.62202.47----
Upgrade
Debt / Equity Ratio
0.520.520.460.370.170.00
Upgrade
Debt / EBITDA Ratio
6.226.22----
Upgrade
Net Debt / Equity Ratio
0.100.100.04-0.03-0.23-0.46
Upgrade
Net Debt / EBITDA Ratio
1.241.24-0.490.452.0117.11
Upgrade
Net Debt / FCF Ratio
-3.56-3.56-0.570.121.195.60
Upgrade
Asset Turnover
0.380.380.230.240.160.18
Upgrade
Inventory Turnover
1.001.001.021.441.271.79
Upgrade
Quick Ratio
0.920.920.931.321.877.52
Upgrade
Current Ratio
1.321.321.381.782.428.94
Upgrade
Return on Equity (ROE)
0.76%0.76%-12.66%-6.54%-9.89%-2.25%
Upgrade
Return on Assets (ROA)
1.15%1.15%-4.91%-3.90%-6.94%-2.70%
Upgrade
Return on Invested Capital (ROIC)
0.98%0.99%-12.86%-10.51%-21.05%-9.64%
Upgrade
Return on Capital Employed (ROCE)
2.90%2.90%-11.60%-8.40%-13.00%-4.60%
Upgrade
Earnings Yield
-0.27%-0.28%-4.27%-1.44%-2.80%-0.46%
Upgrade
FCF Yield
-0.42%-0.44%-2.48%-4.51%-5.26%-1.64%
Upgrade
Buyback Yield / Dilution
-1.36%-1.36%1.73%-2.17%3.44%-7.71%
Upgrade
Total Shareholder Return
-1.36%-1.36%1.73%-2.17%3.44%-7.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.